Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Comparison of bupropion, fluoxetine, and methylphenidate in cancer-related fatigue
IRCT20180623040193N3Phase 3Completed
- Sponsor
- Shahrekord University of Medical Sciences
- Start
- Aug 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial in cancer-related fatigue (CRF) comparing Bupropion arm, Fluoxetine arm and Methylphenidate arm (3 arms). Started Aug 2020; status: completed.
02
Drugs
bupropionfluoxetinemethylphenidate
03
Conditions
cancer-related fatigue (CRF)
Beyond the preview
Go deeper on IRCT20180623040193N3.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20180623040193N3.